Escobar, Carlos
Morales, Cristóbal
Capel, Margarita
Simón, Susana
Pérez-Alcántara, Ferran
Pomares, Elisenda
Funding for this research was provided by:
AstraZeneca Spain, Spain
Article History
Received: 8 September 2021
Accepted: 31 January 2022
First Online: 17 February 2022
Declarations
:
: Not applicable. Research ethics was not required as the study did not involve human subjects or materials.
: Not applicable.
: MC and SS are employed by AstraZeneca Spain. FP and EP are employed by Oblikue Consulting, a consultant company specialized in economic evaluations of health interventions and received financial support from AstraZeneca Spain for the development of this study. CE and CM received an honorarium from the sponsor and participated as independent consultants.